ALENDRONATE PLUS D3 70 mg/140 ug APOTEX alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister Australien - engelsk - Department of Health (Therapeutic Goods Administration)

alendronate plus d3 70 mg/140 ug apotex alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 iu) tablet blister

dr reddys laboratories australia pty ltd - colecalciferol, quantity: 0.14 mg; alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: magnesium stearate; povidone; sucrose; butylated hydroxytoluene; croscarmellose sodium; microcrystalline cellulose; gelatin; medium chain triglycerides; colloidal anhydrous silica - alendronate plus d3 70 mg/140 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture

ALENDRONATE PLUS D3 70 mg/70 ug APOTEX alendronate (as sodium) 70 mg and colecalciferol 70 microgram (2800 IU) tablet blister pa Australien - engelsk - Department of Health (Therapeutic Goods Administration)

alendronate plus d3 70 mg/70 ug apotex alendronate (as sodium) 70 mg and colecalciferol 70 microgram (2800 iu) tablet blister pa

dr reddys laboratories australia pty ltd - alendronate sodium, quantity: 91.37 mg (equivalent: alendronic acid, qty 70 mg); colecalciferol, quantity: 0.07 mg - tablet, uncoated - excipient ingredients: gelatin; povidone; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; medium chain triglycerides; butylated hydroxytoluene; magnesium stearate; sucrose - alendronate plus d3 70 mg/70 microgram apotex are indicated for the treatment of: osteoporosis in select patients where vitamin d supplementation is recommended, prior to treatment, osteoporosis must be confirmed by: - the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by - the presence of osteoporotic fracture

MYLANTA 2go ANTACID ORIGINAL chewable tablet (reformulation) blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mylanta 2go antacid original chewable tablet (reformulation) blister pack

johnson & johnson pacific pty ltd - simethicone, quantity: 20 mg; magnesium hydroxide, quantity: 200 mg; aluminium hydroxide, quantity: 200 mg - tablet, chewable - excipient ingredients: mannitol; spearmint oil; purified water; magnesium stearate; maize starch; sucrose; silicon dioxide; dimeticone 1000; dimeticonol; flavour - fast relief from upset stomach, flatulence, wind pain, gastric hyperacidity, indigestion, heartburn and oesophageal reflux.

MYLANTA 2go ANTACID DOUBLE STRENGTH chewable tablet (reformulation) blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mylanta 2go antacid double strength chewable tablet (reformulation) blister pack

johnson & johnson pacific pty ltd - simethicone, quantity: 40 mg; magnesium hydroxide, quantity: 400 mg; aluminium hydroxide, quantity: 400 mg - tablet, chewable - excipient ingredients: mannitol; magnesium stearate; purified water; spearmint oil; silicon dioxide; dimeticone 1000; dimeticonol; flavour; maize starch; sucrose - fast relief from upset stomach, flatulence, wind pain, gastric hyperacidity, indigestion, heartburn and oesophageal reflux.

MYLANTA 2GO ANTACID DUAL ACTION tablet blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mylanta 2go antacid dual action tablet blister pack

johnson & johnson pacific pty ltd - sodium bicarbonate, quantity: 234 mg; magaldrate, quantity: 371 mg; alginic acid, quantity: 215 mg - tablet, chewable - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; saccharin sodium; purified talc; magnesium stearate; mannitol; microcrystalline cellulose; flavour - fast, long lasting relief from the burning pain of heartburn, indigestion and gastric reflux.

MYLANTA P ANTACID chewable tablet blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mylanta p antacid chewable tablet blister pack

johnson & johnson pacific pty ltd - simethicone, quantity: 20 mg; aluminium hydroxide, quantity: 200 mg; magnesium hydroxide, quantity: 200 mg - tablet, chewable - excipient ingredients: purified water; spearmint oil; magnesium stearate; mannitol; flavour; maize starch; sucrose; silicon dioxide; dimeticone 1000; dimeticonol - fast relief from upset stomach, flatulence, wind pain, gastric hyperacidity, indigestion, heartburn and oesophageal reflux.

MYLANTA 2go ANTACID FASTCHEWS chewable tablet blister pack Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mylanta 2go antacid fastchews chewable tablet blister pack

johnson & johnson pacific pty ltd - magnesium hydroxide, quantity: 116.1109 mg; calcium carbonate, quantity: 578.9475 mg - tablet, chewable - excipient ingredients: mannitol; sucralose; crospovidone; menthol; magnesium stearate; pregelatinised maize starch; maize starch; flavour - for fast effective relief of indigestion and heartburn

ALENDROBELL PLUS D3 and CALCIUM alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500 mg tab Australien - engelsk - Department of Health (Therapeutic Goods Administration)

alendrobell plus d3 and calcium alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet and calcium 500 mg tab

dr reddys laboratories australia pty ltd - calcium carbonate, quantity: 1.25 g (equivalent: calcium, qty 500 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; croscarmellose sodium; povidone; magnesium stearate; hypromellose; macrogol 8000; chlorophyllin-copper complex; titanium dioxide; carnauba wax - for the treatment of: ? osteoporosis in select patients where vitamin d and calcium supplementation is recommended,prior to treatment, osteoporosis must be confirmed by: ? the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by ? the presence of osteoporotic fracture

Mylanta 2go Double Strength New Zealand - engelsk - Medsafe (Medicines Safety Authority)

mylanta 2go double strength

jntl consumer health (new zealand) limited - aluminium hydroxide 400mg; magnesium hydroxide 400mg; simeticone 40mg - tablet - 400mg/400mg/40mg - active: aluminium hydroxide 400mg magnesium hydroxide 400mg simeticone 40mg excipient: lemon flavour natural icc-26353 magnesium stearate mannitol purified water spearmint oil sucrose

Mylanta 2go Original New Zealand - engelsk - Medsafe (Medicines Safety Authority)

mylanta 2go original

jntl consumer health (new zealand) limited - aluminium hydroxide 200mg; magnesium hydroxide 200mg; simeticone 20mg - tablet - 200mg/200mg/20mg - active: aluminium hydroxide 200mg magnesium hydroxide 200mg simeticone 20mg excipient: lemon flavour natural icc-26353 magnesium stearate mannitol purified water spearmint oil sucrose